S1:E321 Xanthic Biopharma Inc. (CSE:XTHC) New Listing
Investment Pitch | Season 1
Xanthic, through its wholly-owned operating subsidiary, Xanthic Biopharma Limited, provides valuable intellectual property to cannabis industry participants, enabling its strategic partners to produce high quality, innovative, non-combustible cannabis, and cannabis-infused products which deliver consistent THC and/or CBD levels.